Why the study?
The perioperative surgical outcomes for head and neck cancer patients with cardiovascular diseases were not well established.
Does concomitant cardiovascular disease increase the risk of adverse perioperative outcomes in head and neck cancer patients undergoing surgery?
Does concomitant cardiovascular disease increase the risk of adverse perioperative outcomes in head and neck cancer patients undergoing surgery?
Concomitant cardiovascular disease significantly increases the risk of perioperative complications, mortality, readmissions, and healthcare costs in patients undergoing surgery for head and neck cancer.
CVD may signal higher perioperative risk in head and neck cancer surgery; cross-sectional data leaves open need for prospective validation before changing practice.
BACKGROUND: This study aimed to determine the perioperative surgical outcomes for head and neck cancer patients with cardiovascular diseases (CVDs). METHODS: A cross-sectional analysis was performed using data from the Nationwide Readmissions Database between 2010 and 2014. Logistic regression analysis by enter and backward stepwise methods were used. RESULTS: A total of 8346 patients met the inclusion criteria. Patients with concomitant CVD had a higher frequency of complications (57.6%) compared with those without (47.4%) (odds ratio [OR] = 1.35, 95% confidence interval [CI] = 1.23-1.48, p < 0.001). Patients with CVD comorbidities were prone to experience in-patient mortality at both admission (OR = 2.4, 95% CI = 1.42-4.05) and readmission (OR = 2.55, 95% CI = 1.10-5.87). CVD patients have prolonged hospital admission (OR = 1.14, 95% CI = 1.02-1.27, p = 0.020) and higher cost (OR = 1.28, 95% CI = 1.15-1.43, p < 0.001). Patients with congestive heart failure were prone to 30 days readmission (OR = 1.67, 95% CI = 1.10-2.53, p = 0.019) and 90 days (OR = 1.65, 95% CI = 1.14-2.39, p = 0.010). CONCLUSION: This is the first study identifying factors predicting higher risk of perioperative complications of surgical management of head and neck cancer. Those with CVD had higher risk of adverse events.
No takes yet. Share an insight, caveat, or question.
Attia et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: